DENVER--(BUSINESS WIRE)--Accelr8 Technology Corporation (NYSE Amex: AXK) announced that one of its outside principal investigators received acceptance to present results of a new study in Europe. Researchers from the Washington University in St. Louis School of Medicine (the Barnes-Jewish Hospital) will present at the 21st annual ECCMID to be held May 7-10, 2011 in Milan, Italy. ECCMID is the European Congress of Clinical Microbiology and Infectious Disease, www.eccmid-icc2011.org. It is a major international meeting for professionals in clinical microbiology and Infectious Diseases Medicine.
